Compare LyondellBasell Industries NV (LYB) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LyondellBasell Industries NV vs Moderna, Inc. — how do they compare? LyondellBasell Industries NV trades at $61.65 (market cap $19.60B), while Moderna, Inc. trades at $59.38 (market cap $23.60B). The key difference: Moderna, Inc. is the larger of the two by market cap, and LyondellBasell Industries NV pays a 6.78% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| LYB | MRNA | |
|---|---|---|
Market Cap | $19.60B | $23.60B |
Sector | Basic Materials | Health |
52-Week High | $82.38 | $81.80 |
52-Week Low | $42.28 | $22.36 |
Enterprise Value | $31.22B | $19.70B |
Dividend Yield | 6.78% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
